The Ron receptor tyrosine kinase in prostate cancer.Megan N. Thobe(University of Cincinnati)OhioLink ETD Center (Ohio Library and Information Network)January 1, 2010Cited by 0SaveCiteExport RISWatch citationsRelated PapersAbstract 2339: Prevalence of MET expression, activating mutations of KRAS and IDH1/2, and ROS1 fusions in cholangiocarcinoma patient tumor samples.|Cancer Research|2013|3